Kotta Kranthi Kumar*
SKU College of Pharmaceutical Sciences, S. K. University, Anantapuramu, A.P, India.
*Address for Corresponding Author
Kotta Kranthi Kumar
Department of Pharmaceutics, SKU College of Pharmaceutical Sciences, S. K. University, Anantapuramu, A.P, India.
The IBC's primary objective is to safeguard protection of personnel, the general public, and the environment. Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of recombinant DNA research. To meet this goal, the IBC imposes requirements for safe laboratory and biological safety practices; reviews and approves policies, procedures, training, programs and facilities pursuant to the safe use of biological agents, other biological materials, and toxins. The IBC is responsible for reviewing and approving those research and teaching activities conducted by faculty, staff, students, and/or visiting scientists on Cornell property, and/or under the control of Cornell faculty, staff or students, that involve the use of biohazardous materials including regulated animal and plant pathogens, biological toxins, and recombinant or synthetic nucleic acid molecules. The Institutional Biosafety Committee (IBSC) is a statutory committee of an organisation undertaking r-DNA activities, constituted as per provisions of Rules, 1989 and chaired by the Head of the organisation or his designate.
Keywords: Institutional Biosafety Committee, recombinant DNA, Department of Biotechnology, National institute of Health